RCM

RA Capital Management Portfolio holdings

AUM $8.12B
1-Year Est. Return 46.06%
This Quarter Est. Return
1 Year Est. Return
+46.06%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$8.12B
AUM Growth
+$2.18B
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
78
New
Increased
Reduced
Closed

Top Buys

1 +$108M
2 +$64.8M
3 +$59.9M
4
MLYS icon
Mineralys Therapeutics
MLYS
+$44.6M
5
PEPG icon
PepGen
PEPG
+$43.3M

Top Sells

1 +$92.5M
2 +$48.1M
3 +$40.6M
4
ELVN icon
Enliven Therapeutics
ELVN
+$17M
5
HNGE
Hinge Health
HNGE
+$15.5M

Sector Composition

1 Healthcare 99.83%
2 Financials 0.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GERN icon
26
Geron
GERN
$747M
$82.7M 1.02%
60,379,366
TSHA icon
27
Taysha Gene Therapies
TSHA
$1.24B
$77M 0.95%
23,555,648
BLTE
28
Belite Bio
BLTE
$5.25B
$64.8M 0.8%
+875,000
CLYM
29
Climb Bio
CLYM
$123M
$63.2M 0.78%
31,419,267
SRRK icon
30
Scholar Rock
SRRK
$4.4B
$43.5M 0.54%
1,166,788
+30,335
GPCR icon
31
Structure Therapeutics
GPCR
$2.13B
$42.5M 0.52%
1,517,418
MNPR icon
32
Monopar Therapeutics
MNPR
$570M
$41.8M 0.51%
511,207
FDMT icon
33
4D Molecular Therapeutics
FDMT
$606M
$39.7M 0.49%
4,563,211
SLDB icon
34
Solid Biosciences
SLDB
$402M
$35.9M 0.44%
5,811,423
+100
MTSR
35
DELISTED
Metsera Inc
MTSR
$35.4M 0.44%
675,525
ARTV
36
Artiva Biotherapeutics
ARTV
$88.4M
$28.3M 0.35%
9,853,302
LBRX
37
LB Pharmaceuticals
LBRX
$431M
$28.1M 0.35%
+1,776,958
TVTX icon
38
Travere Therapeutics
TVTX
$3.12B
$27.5M 0.34%
1,150,000
ASMB icon
39
Assembly Biosciences
ASMB
$553M
$26.1M 0.32%
+1,020,410
ABOS icon
40
Acumen Pharmaceuticals
ABOS
$116M
$25.5M 0.31%
14,932,063
CTNM
41
Contineum Therapeutics
CTNM
$313M
$24.9M 0.31%
+2,122,000
NKTX icon
42
Nkarta
NKTX
$129M
$22.4M 0.28%
10,805,129
LRMR icon
43
Larimar Therapeutics
LRMR
$311M
$19.5M 0.24%
6,045,351
IVVD icon
44
Invivyd
IVVD
$704M
$18.8M 0.23%
+17,119,096
TNGX icon
45
Tango Therapeutics
TNGX
$1.38B
$16.8M 0.21%
2,000,000
PRME icon
46
Prime Medicine
PRME
$635M
$16.6M 0.2%
+3,000,000
RCUS icon
47
Arcus Biosciences
RCUS
$3.14B
$15.5M 0.19%
1,136,364
ACRV icon
48
Acrivon Therapeutics
ACRV
$76.4M
$15.1M 0.19%
8,340,508
HOWL icon
49
Werewolf Therapeutics
HOWL
$46.6M
$13.2M 0.16%
6,681,307
QURE icon
50
uniQure
QURE
$1.65B
$11.7M 0.14%
+200,000